
Vital Signs with Jacob Effron and Nikhil Krishnan
On Vital Signs, Jacob Effron and Nikhil Krishnan dig into cutting-edge trends in healthtech and the people shaping them. Every two weeks they’ll explore a new sub-sector and trend with policy leaders, startup founders and industry executives. Subscribe now to make sure you don’t miss any of it!
Show episodes

Ep 57: Taro Health CEO Frank Wu on Direct Primary Care, The History of InsurTech and AI for Payers
Jacob and Nikhil sit down with Frank Wu, the Co-Founder and CEO of Taro Health. Taro Health is a health insurance plan currently live in Maine and Oklahoma that offers unlimited primary care and mental health visits. The company has raised over $18m from investors like Hummingbird Ventures, Quiet Capital, and FPV Ventu

Ep 56: Providence CEO Erik Wexler on Evaluating Partnerships, Policy and Leadership
Jacob sits down with Erik Wexler, the President and CEO of Providence. Providence is a non-profit, faith-based health system with 51 hospitals and 1,000 clinics across seven states. They discuss how to think about new AI opportunities with discipline, the value of health system partnerships, programs to support health

Ep 55: Hinge Health CEO Daniel Perez on Effective Employer Sales, Patient Engagement and His Top Advice to Founders
Jacob and Nikhil sit down with Daniel Perez, the Co-Founder and CEO of Hinge Health. Hinge Health is a digital clinic for patients with joint and muscle pain, having raised $800M+ from investors like Coatue and Tiger Global. They discuss Hinge Health’s strategy for selling to employers, how digital health solutions can

Ep 54: General Catalyst CEO Hemant Taneja on Buying a Health System, $100B Healthcare Companies and The Future of AI and Venture
Jacob sits down with Hemant Taneja, the CEO & Managing Director of General Catalyst. GC is one of the world’s largest venture capital firms, most recently raising an $8B fund in 2024. The firm has invested in companies like Livongo, Cityblock Health, and Hippocratic AI. They discuss the possibility of a $100B healthcar

Ep 53: Cradle CEO Stef van Grieken on the State of AI x Bio and Selling SaaS to Pharma
Jacob sits down with Stef van Grieken, Co-Founder & CEO of Cradle. Cradle has raised over $100M from investors like IVP and Index Ventures to build and expand their AI-enabled protein engineering platform. They discuss how Cradle plans to use their new Series B funding, what’s been happening in AI bio, the technical un

Ep 52: knownwell CMO Dr. Angela Fitch on The Future of GLP-1s and New Approaches to Obesity Medicine
Jacob sits down with Dr. Angela Fitch, the Founder and CMO of knownwell. knownwell has raised $25 million from investors like a16z and Flare Capital Partners to provide weight-inclusive primary care and metabolic health care. They discuss the future of obesity care, where we are with GLP-1s, the need to expand coverage